IsoTherapeutics Group
Angleton, Texas, United States
About IsoTherapeutics Group
IsoTherapeutics Group, LLC (IsoTherapeutics) is a radiopharmaceutical company that was founded in 2005 by two entrepreneur scientists with a passion for advancing the technology of radiopharmaceuticals. The company scientists, while employed at the Dow Chemical Company, developed QUADRAMET® a radiopharmaceutical for treatment of bone pain due to metastatic cancer, treatments for arthritis, osteoporosis, and osteomyelitis, just to name a few. IsoTherapeutics scientists have received over 100 patents for developing chemistry and radiopharmaceutical formulations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Website: isotherapeutics.com
- Phone: (979) 848-0800
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/isotherapeutics-group-2499971 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.